Publications by authors named "Holly Posner"

Claim this Profile
T
Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial.
Hermine I Brunner, Ekaterina Alexeeva, Marcia Bandeira, Ruy Carrasco, Jeffrey Chaitow, Holly B Posner

Arthritis Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study.
Hermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, John F Bohnsack, Alina Lucica Boteanu, Holly Posner

Ann Rheum Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata.
Samira Anderson, Guido Cavaletti, Linda J Hood, Michael Polydefkis, David N Herrmann, Holly B Posner

Pharmacol Res Perspect· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib for juvenile idiopathic arthritis - Authors' reply.
Nicolino Ruperto, Hermine I Brunner, Holly B Posner, Irina Lazariciu, Alberto Martini

Lancet· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial.
Nicolino Ruperto, Hermine I Brunner, Olga Synoverska, Tracy V Ting, Carlos Abud Mendoza, Holly B Posner

Lancet· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.
Holly Posner, Rosie Curiel, Chris Edgar, Suzanne Hendrix, Enchi Liu

Innov Clin Neurosci· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum.
Philip D Harvey, Stephanie Cosentino, Rosie Curiel, Terry E Goldberg, Jeffrey Kaye, Holly Posner

Innov Clin Neurosci· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
Sid E O'Bryant, Michelle M Mielke, Robert A Rissman, Simone Lista, Hugo Vanderstichele, Holly Posner

Alzheimers Dement· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive pregabalin vs gabapentin for focal seizures: Interpretation of comparative outcomes.
Jacqueline French, Paul Glue, Daniel Friedman, Mary Almas, Nandan Yardi, Holly B Posner

Neurology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research.
Sid E O'Bryant, Veer Gupta, Kim Henriksen, Melissa Edwards, Andreas Jeromin, Holly Posner

Alzheimers Dement· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjunctive use of controlled-release pregabalin in adults with treatment-resistant partial seizures: a double-blind, randomized, placebo-controlled trial.
Jacqueline French, Christian Brandt, Daniel Friedman, Victor Biton, Lloyd Knapp, Holly B Posner

Epilepsia· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
Gaetano Zaccara, Mary Almas, Verne Pitman, Lloyd Knapp, Holly Posner

Epilepsia· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putting the Alzheimer's cognitive test to the test I: traditional psychometric methods.
Jeremy Hobart, Stefan Cano, Holly Posner, Ola Selnes, Yaakov Stern

Alzheimers Dement· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Putting the Alzheimer's cognitive test to the test II: Rasch Measurement Theory.
Jeremy Hobart, Stefan Cano, Holly Posner, Ola Selnes, Yaakov Stern

Alzheimers Dement· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: a new approach.
Holly B Posner, Stefan Cano, Maria C Carrillo, Ola Selnes, Yaakov Stern

Alzheimers Dement· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.
Mark W Logue, Holly Posner, Richard C Green, Margaret Moline, L Adrienne Cupples

Alzheimers Dement· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of cognition in early dementia.
Nina B Silverberg, Laurie M Ryan, Maria C Carrillo, Reisa Sperling, Ronald C Petersen, Holly B Posner

Alzheimers Dement· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ADAS-cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts.
Stefan J Cano, Holly B Posner, Margaret L Moline, Stephen W Hurt, Jina Swartz

J Neurol Neurosurg Psychiatry· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, placebo-controlled, clinical trial of donepezil in vascular dementia: differential effects by hippocampal size.
Gustavo C Román, Stephen Salloway, Sandra E Black, Donald R Royall, Charles Decarli, Holly Posner

Stroke· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
David Wilkinson, Gustavo Róman, Stephen Salloway, Jane Hecker, Karyn Boundy, Holly Posner

Int J Geriatr Psychiatry· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scales as outcome measures for Alzheimer's disease.
Ronald Black, Barry Greenberg, J Michael Ryan, Holly Posner, Jeffrey Seeburger

Alzheimers Dement· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.
Martin Dichgans, Hugh S Markus, Stephen Salloway, Auli Verkkoniemi, Margaret Moline, Holly Posner

Lancet Neurol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuroradiological findings in vascular dementia.
Ali Guermazi, Yves Miaux, Alex Rovira-Cañellas, Joyce Suhy, Jon Pauls, Holly Posner

Neuroradiology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis